Site records / India / FEI 3013697420
BioMylz Pvt. Ltd.Bengaluru
FDA-registered drug establishment in Bengaluru: manufacture. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.
- Inspections posted
- 2
- Last inspection
- Feb 2026 · OAI
- Warning letters to this FEI
- 1
- Import alerts at this address
- 1
- US border refusals, 2 years
- 0
This site, graded.
Every fact sourced.
- A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
- Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
- Warning-letter violations, numbered and labelled
- Import-alert history rebuilt from the archive, each listing checked against this address
- Border refusals by product, and the company's other sites, each graded
- A hash of every source read, so the PDF can be checked against the record
On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.
PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.
By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.
Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan
Inspections
2 FDA inspections of this FEI, by end date; 2 with a posted classification.
- 9 Feb 2026OAI · Official Action IndicatedDrug Quality Assurance · no citations posted
- 7 Feb 2020VAI · Voluntary Action IndicatedDrug Quality Assurance · 17 citations posted
Warning letters and compliance actions
- 13 Jul 2026Warning Letter · CDER SourceCGMP/Finished Pharmaceuticals/Adulterated/Misbranded
Import alerts in force
Import-alert pages list a firm name and an address, never an FEI. Each listing under this firm's name is shown with the address FDA published and whether it is this site's.
- 24 Apr 2024Import alert 66-41 · Published address is this site SourceDetention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.Published address: Building No.1, #21-D, 2nd Phase, Peenya Industrial Area , Bengaluru, Karnataka INDIA
Registration
- FEI
- 3013697420
- DUNS
- 860479936
- Registered as
- BioMylz Pvt. Ltd.
- Registrant
- BioMylz Pvt Ltd.
- Address
- Building No.1, #21-D, 2nd Phase, Peenya Industrial Area, Bengaluru, 560058, India (IND)
- Operations
- MANUFACTURE
- Registration expires
- 31 Dec 2026
Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.